|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 9/143 | (2013.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 9/19 | (2013.01) |
| (11) | Number of the document | 3752132 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19703995.1 |
| Date of filing the European patent application | 2019-02-07 | |
| (97) | Date of publication of the European application | 2020-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/052969 |
| Date | 2019-02-07 |
| (87) | Number | WO 2019/158421 |
| Date | 2019-08-22 |
| (30) | Number | Date | Country code |
| 18156509 | 2018-02-13 | EP | |
| 18158053 | 2018-02-22 | EP | |
| 18194237 | 2018-09-13 | EP |
| (72) |
MARTIN, Nolwenn , AT
|
| (73) |
Sandoz AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITION OF BRIGATINIB |
| PHARMACEUTICAL COMPOSITION OF BRIGATINIB |